Compare AQB & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AQB | ACON |
|---|---|---|
| Founded | 1991 | 2008 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 7.4M |
| IPO Year | 2017 | 2022 |
| Metric | AQB | ACON |
|---|---|---|
| Price | $1.16 | $2.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 524.6K | 61.3K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 87.66 | ★ 99.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,472,659.00 | $75,730.00 |
| Revenue This Year | N/A | $87.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 65.62 |
| 52 Week Low | $0.77 | $1.95 |
| 52 Week High | $2.95 | $12.03 |
| Indicator | AQB | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 40.55 |
| Support Level | $0.84 | $1.95 |
| Resistance Level | $1.23 | $2.50 |
| Average True Range (ATR) | 0.08 | 0.18 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 11.62 | 3.24 |
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.